CODX Days Payables Outstanding from 2010 to 2025

CODX Stock  USD 0.75  0.05  7.14%   
Co Diagnostics Days Payables Outstanding yearly trend continues to be fairly stable with very little volatility. Days Payables Outstanding is projected to decline to 122.80 this year. During the period from 2010 to 2025, Co Diagnostics Days Payables Outstanding regression line of annual values had r-squared of  0.0006 and arithmetic mean of  4,153. View All Fundamentals
 
Days Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
129.26556214
Current Value
122.8
Quarterly Volatility
12.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Days Payables Outstanding Growth Pattern

Below is the plot of the Days Payables Outstanding of Co Diagnostics over the last few years. It is Co Diagnostics' Days Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Days Payables Outstanding10 Years Trend
Very volatile
   Days Payables Outstanding   
       Timeline  

CODX Days Payables Outstanding Regression Statistics

Arithmetic Mean4,153
Geometric Mean401.72
Coefficient Of Variation302.91
Mean Deviation6,242
Median963.32
Standard Deviation12,579
Sample Variance158.2M
Range49.3K
R-Value(0.02)
Mean Square Error170.3M
R-Squared0.0006
Significance0.93
Slope(68.34)
Total Sum of Squares2.2B

CODX Days Payables Outstanding History

2024 122.8
2023 129.27
2022 63.42
2021 19.16
2020 13.16
2019 19.35
2018 5789.9

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Days Payables Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Payables Outstanding 129.27  122.80 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.